| pubmed-article:11722573 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11722573 | lifeskim:mentions | umls-concept:C0220847 | lld:lifeskim |
| pubmed-article:11722573 | lifeskim:mentions | umls-concept:C0035736 | lld:lifeskim |
| pubmed-article:11722573 | lifeskim:mentions | umls-concept:C0205147 | lld:lifeskim |
| pubmed-article:11722573 | lifeskim:mentions | umls-concept:C0035668 | lld:lifeskim |
| pubmed-article:11722573 | lifeskim:mentions | umls-concept:C0035685 | lld:lifeskim |
| pubmed-article:11722573 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
| pubmed-article:11722573 | lifeskim:mentions | umls-concept:C1883725 | lld:lifeskim |
| pubmed-article:11722573 | lifeskim:mentions | umls-concept:C0205088 | lld:lifeskim |
| pubmed-article:11722573 | pubmed:issue | 22 | lld:pubmed |
| pubmed-article:11722573 | pubmed:dateCreated | 2001-11-27 | lld:pubmed |
| pubmed-article:11722573 | pubmed:abstractText | The NS5B protein, or RNA-dependent RNA polymerase of the hepatitis virus type C, catalyzes the replication of the viral genomic RNA. Little is known about the recognition domains of the viral genome by the NS5B. To better understand the initiation of RNA synthesis on HCV genomic RNA, we used in vitro transcribed RNAs as templates for in vitro RNA synthesis catalyzed by the HCV NS5B. These RNA templates contained different regions of the 3' end of either the plus or the minus RNA strands. Large differences were obtained depending on the template. A few products shorter than the template were synthesized by using the 3' UTR of the (+) strand RNA. In contrast the 341 nucleotides at the 3' end of the HCV minus-strand RNA were efficiently copied by the purified HCV NS5B in vitro. At least three elements were found to be involved in the high efficiency of the RNA synthesis directed by the HCV NS5B with templates derived from the 3' end of the minus-strand RNA: (a) the presence of a C residue as the 3' terminal nucleotide; (b) one or two G residues at positions +2 and +3; (c) other sequences and/or structures inside the following 42-nucleotide stretch. These results indicate that the 3' end of the minus-strand RNA of HCV possesses some sequences and structure elements well recognized by the purified NS5B. | lld:pubmed |
| pubmed-article:11722573 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11722573 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11722573 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11722573 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11722573 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11722573 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11722573 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11722573 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11722573 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11722573 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:11722573 | pubmed:issn | 0014-2956 | lld:pubmed |
| pubmed-article:11722573 | pubmed:author | pubmed-author:VenturaMM | lld:pubmed |
| pubmed-article:11722573 | pubmed:author | pubmed-author:LitvakSS | lld:pubmed |
| pubmed-article:11722573 | pubmed:author | pubmed-author:CastroviejoMM | lld:pubmed |
| pubmed-article:11722573 | pubmed:author | pubmed-author:Sarih-CottinL... | lld:pubmed |
| pubmed-article:11722573 | pubmed:author | pubmed-author:Astier-GinTT | lld:pubmed |
| pubmed-article:11722573 | pubmed:author | pubmed-author:ReigadasSS | lld:pubmed |
| pubmed-article:11722573 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11722573 | pubmed:volume | 268 | lld:pubmed |
| pubmed-article:11722573 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11722573 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11722573 | pubmed:pagination | 5857-67 | lld:pubmed |
| pubmed-article:11722573 | pubmed:dateRevised | 2007-7-23 | lld:pubmed |
| pubmed-article:11722573 | pubmed:meshHeading | pubmed-meshheading:11722573... | lld:pubmed |
| pubmed-article:11722573 | pubmed:meshHeading | pubmed-meshheading:11722573... | lld:pubmed |
| pubmed-article:11722573 | pubmed:meshHeading | pubmed-meshheading:11722573... | lld:pubmed |
| pubmed-article:11722573 | pubmed:meshHeading | pubmed-meshheading:11722573... | lld:pubmed |
| pubmed-article:11722573 | pubmed:meshHeading | pubmed-meshheading:11722573... | lld:pubmed |
| pubmed-article:11722573 | pubmed:meshHeading | pubmed-meshheading:11722573... | lld:pubmed |
| pubmed-article:11722573 | pubmed:meshHeading | pubmed-meshheading:11722573... | lld:pubmed |
| pubmed-article:11722573 | pubmed:meshHeading | pubmed-meshheading:11722573... | lld:pubmed |
| pubmed-article:11722573 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11722573 | pubmed:articleTitle | HCV RNA-dependent RNA polymerase replicates in vitro the 3' terminal region of the minus-strand viral RNA more efficiently than the 3' terminal region of the plus RNA. | lld:pubmed |
| pubmed-article:11722573 | pubmed:affiliation | UMR 5097 CNRS Université Victor Ségalen Bordeaux 2, IFR 66 Pathologies Infectieuses, Bordeaux, France. | lld:pubmed |
| pubmed-article:11722573 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11722573 | pubmed:publicationType | In Vitro | lld:pubmed |
| pubmed-article:11722573 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11722573 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11722573 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11722573 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11722573 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11722573 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11722573 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11722573 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11722573 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11722573 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11722573 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11722573 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11722573 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11722573 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11722573 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11722573 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11722573 | lld:pubmed |
